Function and Regulation of Islet-associated Macrophages in Obesity and Diabetes

项目摘要 申请人的职业目标是制定一个多学科的研究计划，重点是确定如何 炎症有助于代谢疾病的发展。过去十年的新兴数据 揭示了肥胖诱导的代谢性炎症是2型糖尿病发病机制的关键驱动力。 糖尿病（T2DM）。在脂肪组织、肝脏和肌肉中，众所周知，肥胖导致 活化的促炎性巨噬细胞和其他白细胞的进行性浸润， 导致胰岛素抵抗和代谢功能障碍。目前，对是否和 胰岛相关巨噬细胞如何促进胰岛炎症、葡萄糖耐受不良和β细胞 2型糖尿病的功能障碍。此外，胰岛相关巨噬细胞的表型、功能和调节 在代谢性炎症和T2DM的进展过程中，尚未完全确定， 我们对这一严重代谢性疾病的发病机制的理解。这个问题的核心假设是 肥胖诱导的代谢应激导致促炎性巨噬细胞的积累 胰岛内的β细胞功能障碍。为了验证这个假设并开始揭示 胰岛相关巨噬细胞在T2DM进展中的作用，提出了三个具体目标。要求1 将确定胰岛相关巨噬细胞的免疫表型和炎症特征， 小鼠模型中葡萄糖耐受不良和T2DM的进展。目标2将定义beta之间的相互作用 细胞内质网（ER）应激以及胰岛相关巨噬细胞的募集和活化。目标3 将研究促炎巨噬细胞对肥胖症患者β细胞分泌功能的影响， 2型糖尿病。研究计划中概述的各种实验方法将使申请人能够拓宽 他的糖尿病专业知识，通过开发新的专业知识和补充技能，在评估β 小鼠模型、分离的胰岛和常用的β细胞系中的细胞功能。申请人将受益 来自赫尔曼B威尔斯儿科研究中心基础糖尿病研究组的培训 在印第安纳州大学医学院，有五个实验室致力于 了解导致所有形式糖尿病发展的分子机制。这 胰岛生物学的新培训将补充申请人以前在生理学，代谢， 肥胖引起的炎症一个由资深调查人员组成的多元化团队将监督申请人的职业生涯 在获奖期间，通过对他的研究培训做出智力贡献， 指导，并提供职业建议。

Project Summary The applicant's career goal is to develop a multidisciplinary research program focused on defining how inflammation contributes to the development of metabolic disease. Emerging data from the past decade has revealed that obesity-induced metabolic inflammation is a key driving force in the pathogenesis of Type 2 diabetes mellitus (T2DM). In the adipose tissue, liver, and muscle, it is well recognized that obesity leads to progressive infiltration of activated pro-inflammatory macrophages and other leukocytes that act in concert to induce insulin resistance and metabolic dysfunction. At present, relatively little is known about whether and how islet-associated macrophages contribute to islet inflammation, glucose intolerance, and beta cell dysfunction in T2DM. Furthermore, the phenotype, function, and regulation of islet-associated macrophages during the progression of metabolic inflammation and T2DM have yet to be fully defined, leaving critical gaps in our understanding of the pathogenesis of this serious metabolic disease. The central hypothesis of this application is that obesity-induced metabolic stress causes the accumulation of pro-inflammatory macrophages within the islet that exacerbate beta cell dysfunction in T2DM. To test this hypothesis and to begin to uncover the role of islet-associated macrophages in the progression of T2DM, three Specific Aims are proposed. Aim 1 will determine the immunophenotype and inflammatory profile of islet-associated macrophages during the progression of glucose intolerance and T2DM in mouse models. Aim 2 will define the interplay between beta cell endoplasmic reticulum (ER) stress and recruitment and activation of islet-associated macrophages. Aim 3 will investigate the effects of pro-inflammatory macrophages on beta cell secretory function in obesity and T2DM. The diverse experimental approaches outlined in the research plan will allow the applicant to broaden his diabetes expertise by developing new proficiencies and complementary skill sets in the assessment of beta cell function in mouse models, isolated islets, and commonly used beta cell lines. The applicant will benefit from training in the Basic Diabetes Research Group within the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, which houses five laboratories that are committed to understanding the molecular mechanisms that lead to the development of all forms of diabetes mellitus. This new training in islet biology will complement the applicant's previous training in physiology, metabolism, and obesity-induced inflammation. A diverse team of established investigators will oversee the applicant's career development during the award period by contributing intellectually to his research training, providing mentorship, and offering career advice.